Quality and reproducibility issues related to clinical development – EATRIS Webinar series (6/6)
|Date & Time||February 18 2020, 14.00 -15.00 CET|
- Christine Toneatti (ECRIN)
This webinar is dedicated to quality and reproducibility issues encountered during clinical development. Christine Toneatti from ECRIN will address how to ensure high quality of data collected during and after clinical trials. She will highlight the importance of reusing and sharing of datasets and how best to rely on existing datasets and profit from what was done earlier.
An interactive Q&A session will conclude this 60-minute-webinar.
Reproducibility is a foundational element of the scientific method, a benchmark upon which the reliability of an experiment can be tested. However, the field is facing alarmingly high irreproducibility rates as illustrated in various industry publications, with reports ranging from 50% to 80% of published results not being reproducible. It has been estimated that in the US alone, $28B in funding is spent on preclinical research that is not reproducible. This estimation does not even consider the impact on delaying translational research and causing high failure rates observed for the development of new treatments.
In this context, EATRIS will run a series of webinars this fall, looking at reproducibility issues experienced during specific phases of the drug development pipeline (screening, preclinical models, biomarker development & analytical platforms, clinical validation). The aim is to bring best practices together and to discuss solutions designed to tackle the identified bottlenecks.
You will have the chance to get the latest updates from experts in the field as well as participate in a Q&A session at the end of the lecture. Please note that you will have the opportunity to watch again later as all webinars will be recorded.